Home
Mail
News
Sports
Finance
Celebrity
Style
Movies
Weather
Mobile
Yahoo
Mail
News
Taxes
Watchlists
My Portfolio
My Screeners
Market Data
Industry News
Real Estate
Technology
Currency Converter
Canada markets closed
S&P/TSX
22,308.93
+361.53
(+1.65%)
S&P 500
5,222.68
+94.89
(+1.85%)
DOW
39,512.84
+837.14
(+2.16%)
CAD/USD
0.7314
+0.0005
(+0.07%)
CRUDE OIL
78.07
-0.19
(-0.24%)
Bitcoin CAD
83,849.00
+507.25
(+0.61%)
Ultragenyx Pharmaceutical Inc. (RARE)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.90
-0.32
(-0.78%)
At close: 04:00PM EDT
40.00
-0.90
(-2.20%)
After hours:
04:05PM EDT
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
442,586
434,249
363,329
351,406
271,030
Cost of Revenue
50,485
45,209
28,320
16,008
6,129
Gross Profit
392,101
389,040
335,009
335,398
264,901
Operating Expenses
Research Development
661,238
648,449
705,789
497,153
412,084
Selling General and Administrative
311,313
309,799
278,139
219,982
182,933
Total Operating Expenses
972,551
958,248
983,928
717,135
595,017
Operating Income or Loss
-580,450
-569,208
-648,919
-381,737
-330,116
Interest Expense
66,215
66,004
43,015
29,422
33,291
Total Other Income/Expenses Net
2,227
60
-20,865
-43,750
171,010
Income Before Tax
-615,216
-608,464
-701,725
-452,981
-185,359
Income Tax Expense
-1,865
-1,825
5,696
1,044
1,207
Income from Continuing Operations
-613,351
-606,639
-707,421
-454,025
-186,566
Net Income
-613,351
-606,639
-707,421
-454,025
-186,566
Net Income available to common shareholders
-613,351
-606,639
-707,421
-454,025
-186,566
Basic EPS
-8.97
-
-10.12
-6.70
-3.07
Diluted EPS
-8.97
-
-10.12
-6.70
-3.07
Basic Average Shares
70,780
-
69,914
67,796
60,846
Diluted Average Shares
70,780
-
69,914
67,796
60,846
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy Dashboard
About Our Ads
© 2024 Yahoo. All rights reserved.